These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 8688836)

  • 1. A mathematical model of periodically pulsed chemotherapy: tumor recurrence and metastasis in a competitive environment.
    Panetta JC
    Bull Math Biol; 1996 May; 58(3):425-47. PubMed ID: 8688836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A mathematical model of drug resistance: heterogeneous tumors.
    Panetta JC
    Math Biosci; 1998 Jan; 147(1):41-61. PubMed ID: 9401351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A mathematical model of the development of drug resistance to cancer chemotherapy.
    Birkhead BG; Rankin EM; Gallivan S; Dones L; Rubens RD
    Eur J Cancer Clin Oncol; 1987 Sep; 23(9):1421-7. PubMed ID: 3678329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A model for metastases formation.
    Markovitch S
    Int J Biomed Comput; 1993 Jan; 32(1):19-33. PubMed ID: 8425750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of optimal drug administration strategies for cancer-chemotherapy in the framework of systems theory.
    Acharya RS; Sundareshan MK
    Int J Biomed Comput; 1984; 15(2):139-50. PubMed ID: 6724730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug kinetics and drug resistance in optimal chemotherapy.
    Costa MI; Boldrini JL; Bassanezi RC
    Math Biosci; 1995 Feb; 125(2):191-209. PubMed ID: 7881194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of optimal control theory in cancer chemotherapy.
    Swan GW
    Math Biosci; 1990 Oct; 101(2):237-84. PubMed ID: 2134485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conflicting objectives in chemotherapy with drug resistance.
    Costa MI; Boldrini JL
    Bull Math Biol; 1997 Jul; 59(4):707-24. PubMed ID: 9214850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal chemotherapy: a case study with drug resistance, saturation effect, and toxicity.
    Costa MI; Boldrini JL; Bassanezi RC
    IMA J Math Appl Med Biol; 1994; 11(1):45-59. PubMed ID: 8057040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer chemotherapy.
    Secchi GC
    Ann Ital Med Int; 1990; 5(3 Pt 3):288-95. PubMed ID: 2081089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapeutic treatments involving drug resistance and level of normal cells as a criterion of toxicity.
    Costa MI; Boldrini JL; Bassanezi RC
    Math Biosci; 1995 Feb; 125(2):211-28. PubMed ID: 7881195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A mathematical model of cancer chemotherapy with an optimal selection of parameters.
    Martin RB; Fisher ME; Minchin RF; Teo KL
    Math Biosci; 1990 May; 99(2):205-30. PubMed ID: 2134520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On mathematical modeling of critical variables in cancer treatment (goals: better understanding of the past and better planning in the future).
    Skipper HE
    Bull Math Biol; 1986; 48(3-4):253-78. PubMed ID: 3828557
    [No Abstract]   [Full Text] [Related]  

  • 14. Mathematical approaches to optimization of cancer chemotherapy.
    Zietz S; Nicolini C
    Bull Math Biol; 1979; 41(3):305-24. PubMed ID: 465827
    [No Abstract]   [Full Text] [Related]  

  • 15. Intensive cytotoxic chemotherapy.
    Bagshawe KD
    J R Coll Physicians Lond; 1971 Jan; 5(2):157-66. PubMed ID: 4131399
    [No Abstract]   [Full Text] [Related]  

  • 16. Some drug-resistant models for cancer chemotherapy. Part 1: Cycle-nonspecific drugs.
    Usher JR; Henderson D
    IMA J Math Appl Med Biol; 1996 Jun; 13(2):99-126. PubMed ID: 8671582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Model for tumour growth with treatment by continuous and pulsed chemotherapy.
    Borges FS; Iarosz KC; Ren HP; Batista AM; Baptista MS; Viana RL; Lopes SR; Grebogi C
    Biosystems; 2014 Feb; 116():43-8. PubMed ID: 24333154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concepts for the treatment of tumor metastasis.
    Griswold DP; Schabel FM; Dykes DJ; Trader MW; Laster WR
    Symp Fundam Cancer Res; 1983; 36():389-96. PubMed ID: 6382515
    [No Abstract]   [Full Text] [Related]  

  • 19. The interval between courses of high-dose chemotherapy with stem cell rescue: therapeutic hypotheses.
    Frei E; Richardson P; Avigan D; Bunnell C; Wheeler C; Elias A
    Bone Marrow Transplant; 1999 Nov; 24(9):939-45. PubMed ID: 10556951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergence of the drug-resistant phenotype in tumor subpopulations: a hybrid model.
    Michelson S; Slate D
    J Natl Cancer Inst; 1989 Sep; 81(18):1392-401. PubMed ID: 2778825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.